Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

Global leading doctors from Vanderbilt and Oxford have published independent clinical validation of the Optellum Lung Cancer Prediction AI, illustrating ...
Read More
Optellum’s lung cancer prediction AI is clinically validated in Thorax

Optellum’s lung cancer prediction AI is clinically validated in Thorax

The Optellum artificial intelligence prediction model has been demonstrated to outperform the best currently used model. Prediction of the likelihood ...
Read More
New Appointments Strengthen Leadership Team

New Appointments Strengthen Leadership Team

/ News and PR, Team
Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of ...
Read More
Optellum co-founder helps start the world's first AI university.

Optellum co-founder helps start the world’s first AI university.

Optellum Chairman & co-founder, Prof. Sir Michael Brady FRS (center), is named the founding Board of Trustees member, and the ...
Read More
Optellum at AI@Oxford Conference

Optellum at AI@Oxford Conference

/ Conference, News and PR
Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer ...
Read More
Optellum Science at the World Conference on Lung Cancer

Optellum Science at the World Conference on Lung Cancer

/ Conference, News and PR
IASLC World Conference on Lung Cancer, the world's premier event for physicians and scientists advancing the fight against world's deadliest ...
Read More
Optellum selected for TMCx Accelerator at the world's largest medical complex

Optellum selected for TMCx Accelerator at the world’s largest medical complex

/ News and PR
The Optellum team is excited to be selected for the 2019 Digital Health Accelerator Cohort at TMCx, to be spend ...
Read More
Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum

Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum

/ Investment, News and PR, Partners
Optellum team and advisors took the lead role in preparing the winning bid, with Optellum Chairman,  Prof Sir Michael Brady ...
Read More
Optellum Science at the IASLC World Conference on Lung Cancer

Optellum Science at the IASLC World Conference on Lung Cancer

/ Conference, News and PR
This week Optellum has been highlighted in three presentations at the IASLC World Conference on Lung Cancer in Toronto, Canada ...
Read More
Prof Sam Janes joins Optellum Medical Advisory Board

Prof Sam Janes joins Optellum Medical Advisory Board

/ Advisors, News and PR
Optellum welcomes an internationally renowned physician and scientist in early lung cancer diagnosis and treatment,  Dr. Sam Janes MD, to join ...
Read More
Meet Optellum at the ATS 2018 Congress

Meet Optellum at the ATS 2018 Congress

/ Event, News and PR
Join us at the American Thoracic Society 2018 Congress in San Diego,  North America's premier congress for pulmonary medicine, from ...
Read More
US National Lung Screening Trial PI visits Optellum

US National Lung Screening Trial PI visits Optellum

/ News and PR, Public Appearances, US
Optellum is delighted to welcome Dr. Christine Berg, the co-Principal Investigator of the US National Lung Screening Trial (NLST), the ...
Read More